Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q3 FY26 Earnings Presentation
45 slides from Zota Health Care's earnings presentation, Feb 5, 2026
Slide 1: Regulation 30 cover letter to NSE
February 05, 2026 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: Investor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirem
Slide 2: Investor Presentation Q3FY26
Investor Presentation Zota Health Care Limited Q3FY26
Slide 3: Safe Harbour
This presentation has been prepared by the Zota Health Care Limited (the “Company”) Safe Harbour only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer
Slide 4: Company Overview
healthcare Itd. Company Overview A zota healthcare Itd.
Slide 5: Zota Healthcare At a Glance
Zota Healthcare At a Glance Financial Highlights (9MFY26 - Consolidated) Zota Health Care Ltd., a Headquartered in Surat and Davaindia, launched in 2017, The strategic business model publicly listed company on employing dedicated is a retail generic pharmacy allows Davaindia to be both NSE, has esta
Slide 6: Our Journey
Our Journey Foundational Steps In Setting Up Formulations Domestic Marketing Export Business Strengthening Core And Pioneering Davaindia 2000 2004 2010 2011 2017 2018 Zota Health Care - Acquired all brand Inaugurated an export- Commenced exports, Introduced Davaindia, a Achieved ₹10+ Cr in Export Sa
Slide 7: Management Profile
Management Profile K e t a nk u m a r Z o t a Moxesh Zota Sujit Paul Chairman And Managing Director Group Chief Executive Officer Non-executive Director Total Experience: 38+ Total Experience: 10+ Total Experience: 23+ • Holds a D-Pharmacy degree • Holds a Bachelor’s degree in pharmacy & • Featured
Slide 8: Company Structure
Company Structure Step down subsidiary Supplying products at ALP* Davaindia Zota Health Care Limited (Listed entity) (Davaindia Health Mart Limited) Procurement in listed entity FOFO Domestic Export COCO (Sales to FOFO# stores) (COCO# stores) FOFO Sales through COCO Sales through Zota Health Care Da
Slide 9: Business Overview
healthcare Itd. Business Overview A zota healthcare Itd.
Slide 10: Business Verticals
Business Verticals DAVAINDIA Revenue contribution (9MFY26) • A Retail generic pharmacy chain providing quality generic medicines. • Focuses only on private-label products in: 02 Store variants 30% – 90% Company Owned Company Operated Savings on medicines as Everyday Herbal Group • Medicinal | OTC |
Slide 11: Case Study – Savings on Davaindia margins
Case Study – Savings on Davaindia margins Company marketed by > Indian Pharma MNC 1 Indian Pharma MNC 2 Davaindia Same Tablet with Significant Tablet / Medicine Name Rosuvas – 10 mg Rosubest - 10 Rosuvastatin 10 same molecule savings in margins Molecule Rosuvastatin 10mg Generic Type Branded Generic
Slide 12: DAVAINDIA
d davaindia’ GENERIC PHARMACY DAVAINDIA
Slide 13: Davaindia - Retail Pharmacy Chain data
Davaindia - Retail Pharmacy Chain data Revolutionizing the generic pharmacy industry with affordable, accessible, quality healthcare solutions through retail pharmacies’ chain. 2000+ 2,331* 1,438 893 SKUs Total no. COCO stores FOFO Stores of stores *As of 31st December 2025 • Launched in 2017, Davai
Slide 14: Davaindia - Operating Model
Davaindia - Operating Model Davaindia Health Mart Limited has Offers a cluster-based store 2,000+ SKUs with 70% medicinal Cloud-based software and AI- implemented a hyperlocal e-commerce model model, optimizing accessibility products and 30% OTC products, with based tools for real-time supply for on
Slide 15: Davaindia - Eliminating traditional supply chain
Davaindia - Eliminating traditional supply chain By sourcing directly from manufacturers and selling straight to consumers, traditional pharma supply chain is eliminated & the cost benefits are transferred to the consumer Average consumer price ~75% savings Doctors on Davaindia medicines as compared
Slide 16: Strengthening the Visibility
Strengthening the Visibility Zota Group Welcomes Mr. Mahendra Singh Dhoni & Mr. Suniel Shetty as Brand Ambassador of Davaindia 15
Slide 17: Davaindia – What are COCO Stores
Davaindia – What are COCO Stores COCO stores are modern walk-in stores providing a distinct contrast to traditional counter-based pharmacies enhancing customer satisfaction and loyalty. Rapid Expansion The timeline for launching a new COCO store has been significantly shortened, enabling faster roll
Slide 18: Davaindia – COCO Stores
Davaindia – COCO Stores 17
Slide 19: Davaindia - COCO Stores
Davaindia - COCO Stores States No. of Stores Company-Owned Company-Operated 1,438 West Bengal 462 Operational Uttar Pradesh Operated by wholly-owned 271 subsidiary 12 COCO stores Maharashtra Davaindia Health142 Mart Ltd 22 Delhi 93 55 68 Enhancing Kerala Store 76 93 Economics Haryana 68 1 Rajasthan
Slide 20: Davaindia COCO - KPI's (1/2)
Davaindia COCO - KPI’s (1/2) No. of Stores Quarterly Footfall in lakhs 1,438 34.3 1,207 29.6 986 23.0 852 19.0 658 15.7 Q3FY25 Q4FY25 Q1FY26 Q2FY26 Q3FY26 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 Q3FY26 19
Slide 21: Davaindia COCO - KPI's (2/2)
Davaindia COCO - KPI’s (2/2) Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ ₹ 7,923 ₹ 6,780 ₹ 231 ₹ 231 ₹ 227 ₹ 229 ₹ 224 ₹ 5,290 ₹ 4,297 ₹ 3,507 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 Q3FY26 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 Q3FY26 20
Slide 22: Same Store Growth Performance: Period Wise Analysis
Same Store Growth Performance: Period Wise Analysis (986 Store – Till June 2025) GMV in ₹lakhs/Month Q3FY25 Q2FY26 Q3FY26 Q3FY26 Old GST Estimated GMV 7.2 4.86 7.02 6.85 6.27 3.39 4.62 4.63 2.75 4.12 2.48 2.07 2.21 3.23 3.22 1.92 1.81 2.62 2.77 2.36 2.58 2.1 2.30 1.83 1.97 1.97 2.04 1.59 1.83 1.60 1
Slide 23: Davaindia – What are FOFO Stores
Davaindia – What are FOFO Stores Franchisee-Owned Franchisee-Operated Asset-light franchise model (FOFO) FOFO stores employ an asset-light franchise model, contributing to the scalability and accessibility of our product offerings. Smaller Store size FOFO stores are compact and over-the-counter form
Slide 24: Davaindia - FOFO Stores
Davaindia - FOFO Stores States No. of Stores Uttar Pradesh 179 16 West Bengal 178 Odisha 113 2 Madhya Pradesh 70 6 Gujarat 61 16 37 3 Maharashtra 41 1 28 Haryana 37 Rajasthan 29 29 12 893 179 Delhi 28 27 Bihar 27 19 Tripura 19 61 70 9 178 Operational FOFO stores Kerala 18 Uttarakhand 16 1 Jammu & Ka
Slide 25: Davaindia FOFO - KPI's (1/2)
Davaindia FOFO - KPI’s (1/2) No. of Stores Quarterly Footfall 893 13.9 14.2 848 759 12.4 730 11.9 697 11.3 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 Q3FY26 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q3FY26 24
Slide 26: Davaindia FOFO - KPI's (2/2)
Davaindia FOFO - KPI’s (2/2) Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ 4,249 ₹ 3,923 ₹ 299 ₹ 3,385 ₹ 3,488 ₹ 3,161 ₹ 285 ₹ 281 ₹ 282 ₹ 279 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q3FY26 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q3FY26 25
Slide 27: OTC and Everyday Herbal Group acquisition
OTC Over-the-counter products Strategic Acquisition as a Acquired 65.98% stake in the Everyday Herbal Group*, move towards backward licensed by the Khadi and Village Industrial Commission, a integration strategic move towards backward integration. OTC products make up ~30% of the stock keeping units
Slide 28: OTC – Products
OTC – Products 27
Slide 29: Davaindia is Revolutionizing the Indian Healthcare Scenario
Davaindia is Revolutionizing the Indian Healthcare Scenario ₹12,172 lacs ~60 % Gross Merchandise Value in Q3FY26 Gross Margin in COCO format 2,331 30-90 % Savings to consumers on Fast growing FOFO & Generic medicines COCO store network* *As of 31st December 2025 25-30 % Mature COCO Stores EBITDA# #
Slide 30: State-Wise Presence of Davaindia Across India
State-Wise Presence of Davaindia Across India (COCO & FOFO Models) States COCO FOFO Total West Bengal 462 178 640 Uttar Pradesh 271 179 450 Maharashtra 142 41 183 Delhi 93 28 121 Odisha 2 113 115 Gujarat 48 61 109 Haryana 68 37 105 Kerala 76 18 94 Madhya Pradesh 18 70 88 Rajasthan 56 29 85 Uttarakha
Slide 31: Davaindia Competitive Edge
Davaindia Competitive Edge The USP of Davaindia: Affordable, Trustworthy, and Innovative Pharmacy Solutions BENEFITS TO THE CUSTOMERS BENEFITS TO THE FRANCHISEES Medicines priced at low MRP thereby ensuring affordability for the masses Store operations and the supply chain efficiently managed by clo
Slide 32: Healthy Repeat Customers
Healthy Repeats Total Average (in %) With a strong base of 80% repeat customers, Davaindia demonstrates a high level of customer satisfaction 80% and loyalty. Repeat Customers 12% New Customers 08% Lost Customers 31
Slide 33: Higher Chronic category share
Higher Click toChronic edit Master category title share style CATEGORY MIX FY25 CATEGORY MIX Q3FY26 57% 60% 27% 27% 16% 13% Chronic OTC Other Chronic OTC Other Higher chronic share: A significant 60% of our revenue comes from chronic disease category, signalling high realization and retention rates,
Slide 34: Supply Chain Management
Click Supply to edit ChainMaster Management title style • The Company has outsourced supply chain management to a third-party warehousing & logistics partner. • A state-of-art central warehousing & processing center has been built in Surat, in Phase 1. • Eventually the Company will replicate such in
Slide 35: Domestic Operations
healthcare Itd. Domestic Operations A zota healthcare Itd.
Slide 36: Domestic Operations
Domestic Operations Marketing Value Chain: Domestic marketing has been the oldest business vertical for the FDF Manufacturers Company and has remained its mainstay in the past. Until 2017, WHO-GMP certified this vertical contributed most of the Company’s revenues. This manufacturing partners busines
Slide 37: Export Operations
healthcare Itd. Export Operations A zota healthcare Itd.
Slide 38: Export Operations
Export Operations Dossiers Registered In Global Markets Our Exports business vertical, which started in 2010, serves 1. Benin 15. Sri Lanka clients in over 30 countries, mainly in the CIS, Latin America, 2. Bolivia 16. Swaziland Africa, and Asia. At its plant in Sachin, SEZ, the Company 3. Cambodia
Slide 39: Financial Overview
healthcare Itd. Financial Overview A zota healthcare Itd.
Slide 40: Management Commentary
Management Commentary “Q3FY26 marked another quarter of strong execution for Zota Health Care, with the Company delivering robust top line growth of 98% yoy driven by continued scale up of the Davaindia store. In Q3FY26 we added 276 stores, taking our footprint to 2,331 Davaindia stores as of 31 Dec
Slide 41: Quarterly Revenue Segmentation
Quarterly Revenue Segmentation Business Verticals – Consolidated Revenue bifurcation Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs Everyday Herbal ₹ lakhs 1,791 451 11,479 1,577 1,501 9,559 1,095 328 911 291 830 4,591 Q3 FY25 Q2 FY26 Q3 FY26 Q3 FY25 Q2 FY26 Q3 FY26 Q3 FY25
Slide 42: Annually Financial Snapshot
Annually Financial Snapshot Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs 6,342 3,190 5,983 5,950 3,014 28,601 5,689 2,670 4,875 2,467 2,004 18,621 10,356 5,578 4,122 FY22 FY23 FY24 FY25 9MFY26 FY22 FY23 FY24 FY25 9MFY26 FY22 FY23 FY24 FY25 9MFY26 Davaindia has driven reven
Slide 43: Business Vertical Performance (Consolidated)
Business Vertical Performance (Consolidated) ₹ in lakhs (Consolidated) Q3 FY26 Particulars Business Vertical Consolidated Davaindia Domestic Exports Everyday Revenue from Operation 11,479.27 1,577.32 910.80 327.75 14,295.14 Cost of Goods Sold 3,782.75 1,056.70 602.75 235.12 5,677.32 Gross Profit 7,6
Slide 44: Profit & Loss Statement (Consolidated)
Profit & Loss Statement (Consolidated) ₹ in lakhs (Consolidated) Particulars Q3FY26 Q2FY26 Q3FY25 9MFY26 9MFY25 FY25 Export Sales (SEZ) 910.80 1,095.00 829.88 2,669.94 1,956.70 3,190.34 Davaindia Sales 11,479.27 9,558.60 4,590.85 28,600.77 12,432.10 18,621.40 Domestic Sales 1,577.32 1,790.50 1,500.6
Slide 45: Thank You
Thank You "ZOTA HOUSE", 2/896, Hira Modi Street, Siddesh Chawan - Sagrampura, -Surat-395 002 (Gujarat) siddesh.chawan@in.ey.com Ajit Mishra - cszota@zotahealthcare.com ajit.j.mishra@in.ey.com www.zotahealthcare.com 44